Delivery Order SPE2DB22D3102-SPE2DB25FL0UB

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,620.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Telmisartan 40mg tablets, a medication used to treat high blood pressure. The contract has a completion date of July 17, 2024 and utilizes a Firm Fixed Price pricing type. This contract is not designated with a set-aside requirement, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,948.67 firm fixed-price delivery order contract is for the supply of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of December 18, 2023. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, with ID SPE2DB25D7056|SPE2DB25FTMGX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,135.93 and a period of performance through April 29, 2025. It is not designated as a...
This federal contract award, valued at $1,275.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure and heart failure. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $5,355.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract has a ceiling value of $7,467.44 and is a firm fixed-price, non-set-aside contract type. It has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,070.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The award is a delivery order against an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,573.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,072.47 firm-fixed-price delivery order is for the supply of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,589.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FL0UB
    Delivery Order

This federal contract award, valued at $1,921.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of April 4, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/3/25, 3:09 PM